These Guru stocks have reached their 52-Week Highs: L Brands Inc. (LTD), Siemens AG (SI), Hess Corp (HES), Dominion Resources Inc. (DCUA), and Valeant Pharmaceuticals International Inc. (VRX).
The prices of L Brands Inc (LTD) shares have reached $61.27, which is 0.1% off the 52-week high of $61.34. Limited Brands is incorporated in the state of Delaware which was founded in 1963. L Brands Inc has a market cap of $17.73 billion; its shares were traded at around $61.27 with a P/E ratio of 23.47 and P/S ratio of 1.71. The dividend yield of L Brands Inc stocks is 1.80%. L Brands Inc had an annual average earnings growth of 10% over the past 10 years. GuruFocus rated L Brands Inc the business predictability rank of 4-star.
On Aug. 8, L Brands Inc. reported net sales of $678.4 million for the four weeks ended Aug. 3, 2013, compared to net sales of $649.8 million for the four weeks ended July 28, 2012. The company reported a comparable store sales increase of 3% for the four weeks ended Aug. 3, 2013, compared to the four weeks ended Aug. 4, 2012. The company reported net sales of $2.516 billion for the 13 weeks ended Aug. 3, 2013, an increase of 5% compared to sales of $2.399 billion for the 13 weeks ended July 28, 2012. The company reported a comparable store sales increase of 2% for the 13 weeks ended Aug. 3, 2013, compared to the 13 weeks ended Aug. 4, 2012.
Last month, CEO/P VS Megabrand Int App Grp Sharen J Turney , CEO-Bath and Body Works Nicholas Coe, and EVP & CFO Stuart B Burgdoerfer sold shares of LTD stock. Director, 10% Owner Leslie H. Wexner and Pres Global Sourcing&Logistics Charles Mcguigan sold shares in April.
On July 31, Siemens released third quarter results for fiscal 2013. Orders for the third quarter rose 19% year-over-year, to €21.141 billion. Revenue was €19.248 billion, 2% below the prior-year level. The book-to-bill ratio was 1.10, and Siemens' order backlog reached a new high at €102 billion. Income from continuing operations was lower year-over-year, at €1.004 billion. Net income rose to €1.098 billion. Corresponding basic EPS was €1.27, up from €0.85 in the prior year period.
Director Steven Mark Cook, bought 14,000 shares of SI stock on 05/14/2013 at the average price of 0.12. Steven Mark Cook, owns at least 310,000 shares after this.
On July 31, Hess Corporation reported net income of $1,431 million for the quarter ended June 30, 2013. Adjusted earnings were $520 million or $1.41 per common share. Net cash provided by operating activities was $1,247 million in the second quarter.
Last week, Director Kevin Omar Meyers bought 750 shares of HES stock. Director John H Mullin III bought 10,000 shares of HES stock in June. Director William G. Schrader bought 2,000 shares in May and Director James H. Quigley bought 360 shares in March.
On Aug. 6, Dominion announced unaudited reported earnings determined in accordance with GAAP for the three months ended June 30, 2013, of $202 million ($0.35 per share), compared to $258 million ($0.45 per share) for the same period in 2012. Operating earnings for the three months ended June 30, 2013, amounted to $355 million ($0.62 per share), compared to originally reported operating earnings of $337 million ($0.59 per share) for the same period in 2012.
The prices of Valeant Pharmaceuticals International shares have reached $101.87, which is 0.7% off the 52-week high of $102.54. Valeant Pharmaceuticals International was formerly known as Biovail Corporation. Valeant Pharmaceuticals International has a market cap of $33.87 billion; its shares were traded at around $101.87 with a P/E ratio of 1075.70 and P/S ratio of 7.73. Valeant Pharmaceuticals International had an annual average earnings growth of 4.2% over the past 10 years.
On Aug. 7, Valeant Pharmaceuticals International Inc. announced second quarter financial results for 2013. Valeant's total revenues were $1.1 billion, up 34% compared to the second quarter of 2012, and product revenues were $1.06 billion, up 43% versus the year-ago quarter. The Company reported net income of $11 million for the second quarter of 2013, or $0.03 per diluted share.
G Mason Morfit and Director Lloyd Mitchell Segal bought shares of VRX stock in June.
L Brands Inc. (LTD) Reached the 52-Week High of $61.27
The prices of L Brands Inc (LTD) shares have reached $61.27, which is 0.1% off the 52-week high of $61.34. Limited Brands is incorporated in the state of Delaware which was founded in 1963. L Brands Inc has a market cap of $17.73 billion; its shares were traded at around $61.27 with a P/E ratio of 23.47 and P/S ratio of 1.71. The dividend yield of L Brands Inc stocks is 1.80%. L Brands Inc had an annual average earnings growth of 10% over the past 10 years. GuruFocus rated L Brands Inc the business predictability rank of 4-star.
On Aug. 8, L Brands Inc. reported net sales of $678.4 million for the four weeks ended Aug. 3, 2013, compared to net sales of $649.8 million for the four weeks ended July 28, 2012. The company reported a comparable store sales increase of 3% for the four weeks ended Aug. 3, 2013, compared to the four weeks ended Aug. 4, 2012. The company reported net sales of $2.516 billion for the 13 weeks ended Aug. 3, 2013, an increase of 5% compared to sales of $2.399 billion for the 13 weeks ended July 28, 2012. The company reported a comparable store sales increase of 2% for the 13 weeks ended Aug. 3, 2013, compared to the 13 weeks ended Aug. 4, 2012.
Last month, CEO/P VS Megabrand Int App Grp Sharen J Turney , CEO-Bath and Body Works Nicholas Coe, and EVP & CFO Stuart B Burgdoerfer sold shares of LTD stock. Director, 10% Owner Leslie H. Wexner and Pres Global Sourcing&Logistics Charles Mcguigan sold shares in April.
Siemens AG (SI) Reached the 52-Week High of $111.68
The prices of Siemens AG shares have reached $111.68, which is 1.3% off the 52-week high of $113.16. Siemens Ag has a market cap of $94.12 billion; its shares were traded at around $111.68 with a P/E ratio of 14.99 and P/S ratio of 0.93. The dividend yield of Siemens Ag stocks is 2.63%. Siemens had an annual average earnings growth of 7.2% over the past 10 years.On July 31, Siemens released third quarter results for fiscal 2013. Orders for the third quarter rose 19% year-over-year, to €21.141 billion. Revenue was €19.248 billion, 2% below the prior-year level. The book-to-bill ratio was 1.10, and Siemens' order backlog reached a new high at €102 billion. Income from continuing operations was lower year-over-year, at €1.004 billion. Net income rose to €1.098 billion. Corresponding basic EPS was €1.27, up from €0.85 in the prior year period.
Director Steven Mark Cook, bought 14,000 shares of SI stock on 05/14/2013 at the average price of 0.12. Steven Mark Cook, owns at least 310,000 shares after this.
Hess Corp (HES) Reached the 52-Week High of $74.89
The prices of Hess Corp shares have reached $74.89, which is 1.9% off the 52-week high of $76.35. Hess Corp has a market cap of $25.71 billion; its shares were traded at around $74.89 with a P/E ratio of 9.26 and P/S ratio of 0.66. The dividend yield of Hess Corp stocks is 0.53%. Hess Corp had an annual average earnings growth of 7.4% over the past 10 years.On July 31, Hess Corporation reported net income of $1,431 million for the quarter ended June 30, 2013. Adjusted earnings were $520 million or $1.41 per common share. Net cash provided by operating activities was $1,247 million in the second quarter.
Last week, Director Kevin Omar Meyers bought 750 shares of HES stock. Director John H Mullin III bought 10,000 shares of HES stock in June. Director William G. Schrader bought 2,000 shares in May and Director James H. Quigley bought 360 shares in March.
Dominion Resources (DCUA) Reached the 52-Week High of $52.21
The prices of Dominion Resources Inc. shares have reached $52.21, which is 0.3% off the 52-week high of $52.36. Dominion Resources Inc. has a market cap of $30.16 billion; its shares were traded at around $52.21 with a P/E ratio of 95.20 and P/S ratio of 2.20.On Aug. 6, Dominion announced unaudited reported earnings determined in accordance with GAAP for the three months ended June 30, 2013, of $202 million ($0.35 per share), compared to $258 million ($0.45 per share) for the same period in 2012. Operating earnings for the three months ended June 30, 2013, amounted to $355 million ($0.62 per share), compared to originally reported operating earnings of $337 million ($0.59 per share) for the same period in 2012.
Valeant Pharmaceuticals International Inc. (VRX) Reached the 52-Week High of $101.87
The prices of Valeant Pharmaceuticals International shares have reached $101.87, which is 0.7% off the 52-week high of $102.54. Valeant Pharmaceuticals International was formerly known as Biovail Corporation. Valeant Pharmaceuticals International has a market cap of $33.87 billion; its shares were traded at around $101.87 with a P/E ratio of 1075.70 and P/S ratio of 7.73. Valeant Pharmaceuticals International had an annual average earnings growth of 4.2% over the past 10 years.
On Aug. 7, Valeant Pharmaceuticals International Inc. announced second quarter financial results for 2013. Valeant's total revenues were $1.1 billion, up 34% compared to the second quarter of 2012, and product revenues were $1.06 billion, up 43% versus the year-ago quarter. The Company reported net income of $11 million for the second quarter of 2013, or $0.03 per diluted share.
G Mason Morfit and Director Lloyd Mitchell Segal bought shares of VRX stock in June.
